Glutamate-urea-based PSMA-targeted PLGA nanoparticles for prostate cancer delivery of docetaxel-Reference-Cited by-同舟云学术

Glutamate-urea-based PSMA-targeted PLGA nanoparticles for prostate cancer delivery of docetaxel

Published:2021-02-04 Issue:4 Volume:26 Page:381-389
ISSN:1083-7450
Container-title:Pharmaceutical Development and Technology
language:en
Short-container-title:Pharmaceutical Development and Technology

Author:

Saniee Fateme¹,Shabani Ravari Nazanin²,Goodarzi Navid¹,Amini Mohsen³,Atyabi Fatemeh¹,Saeedian Moghadam Ebrahim²,Dinarvand Rassoul¹^ORCID

Affiliation:

1. Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

2. Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

3. Department of Medicinal Chemistry, Faculty of Pharmacy and Drug Design & Development Research Center, The Institute of Pharmaceutical Sciences, Tehran University of Medical Sciences, Tehran, Iran

Funder

Nanotechnology Research Centre, Tehran University of Medical Sciences

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/10837450.2021.1875238

Reference33 articles.

1. Epithelial cell adhesion molecule aptamer conjugated PEG–PLGA nanopolymersomes for targeted delivery of doxorubicin to human breast adenocarcinoma cell line in vitro

2. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability

3. 111In- and IRDye800CW-Labeled PLA–PEG Nanoparticle for Imaging Prostate-Specific Membrane Antigen-Expressing Tissues

4. Novel nanoparticles for the delivery of recombinant hepatitis B vaccine

5. Anti-CD24 nano-targeted delivery of docetaxel for the treatment of prostate cancer

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PLGA nanomedical consignation: A novel approach for the management of prostate cancer;International Journal of Pharmaceutics;2024-03

2. Emerging Trends of Nanomedicines in the Management of Prostate Cancer: Perspectives and Potential Applications;Pharmaceutics;2024-02-20

3. Unleashing novel horizons in advanced prostate cancer treatment: investigating the potential of prostate specific membrane antigen-targeted nanomedicine-based combination therapy;Frontiers in Immunology;2023-09-19

4. New insight in urological cancer therapy: From epithelial-mesenchymal transition (EMT) to application of nano-biomaterials;Environmental Research;2023-07

5. Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategies;Biomedicine & Pharmacotherapy;2023-04